BioAtla Statistics
Total Valuation
BioAtla has a market cap or net worth of $6.78 million. The enterprise value is $10.91 million.
| Market Cap | 6.78M |
| Enterprise Value | 10.91M |
Important Dates
The next estimated earnings date is Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BioAtla has 1.66 million shares outstanding. The number of shares has increased by 23.33% in one year.
| Current Share Class | 1.66M |
| Shares Outstanding | 1.66M |
| Shares Change (YoY) | +23.33% |
| Shares Change (QoQ) | +25.56% |
| Owned by Insiders (%) | 7.51% |
| Owned by Institutions (%) | 13.27% |
| Float | 1.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.39 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.15
| Current Ratio | 0.15 |
| Quick Ratio | 0.09 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -133.12% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 411.50% |
| Weighted Average Cost of Capital (WACC) | 4.44% |
| Revenue Per Employee | $48,780 |
| Profits Per Employee | -$1.23M |
| Employee Count | 41 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.37% in the last 52 weeks. The beta is 0.76, so BioAtla's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | -79.37% |
| 50-Day Moving Average | 4.03 |
| 200-Day Moving Average | 19.42 |
| Relative Strength Index (RSI) | 55.63 |
| Average Volume (20 Days) | 71,261 |
Short Selling Information
The latest short interest is 160,104, so 9.65% of the outstanding shares have been sold short.
| Short Interest | 160,104 |
| Short Previous Month | 147,632 |
| Short % of Shares Out | 9.65% |
| Short % of Float | 11.68% |
| Short Ratio (days to cover) | 2.81 |
Income Statement
In the last 12 months, BioAtla had revenue of $2.00 million and -$50.62 million in losses. Loss per share was -$40.15.
| Revenue | 2.00M |
| Gross Profit | -32.90M |
| Operating Income | -49.90M |
| Pretax Income | -50.62M |
| Net Income | -50.62M |
| EBITDA | -49.59M |
| EBIT | -49.90M |
| Loss Per Share | -$40.15 |
Balance Sheet
The company has $1.96 million in cash and $6.09 million in debt, with a net cash position of -$4.13 million or -$2.49 per share.
| Cash & Cash Equivalents | 1.96M |
| Total Debt | 6.09M |
| Net Cash | -4.13M |
| Net Cash Per Share | -$2.49 |
| Equity (Book Value) | -37.31M |
| Book Value Per Share | -22.48 |
| Working Capital | -17.60M |
Cash Flow
| Operating Cash Flow | -37.18M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 310,000 |
| Net Borrowing | 7.13M |
| Free Cash Flow | -37.18M |
| FCF Per Share | -$22.40 |
Margins
| Gross Margin | n/a |
| Operating Margin | -2,494.95% |
| Pretax Margin | -2,530.85% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BioAtla does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.33% |
| Shareholder Yield | -23.33% |
| Earnings Yield | -746.62% |
| FCF Yield | -548.46% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 6, 2026. It was a reverse split with a ratio of 1:50.
| Last Split Date | Apr 6, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
BioAtla has an Altman Z-Score of -111.3 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -111.3 |
| Piotroski F-Score | 1 |